Educating Missouri Patients About Preemptive Living Donor Transplantation
1 other identifier
interventional
370
1 country
5
Brief Summary
This study is a group-randomized controlled trial to explore whether improved community transplant education for renal patients not yet on dialysis could increase patients' willingness to pursue preemptive living donor transplant (PLDT) and PLDT rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2008
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 20, 2009
CompletedFirst Posted
Study publicly available on registry
January 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedSeptember 15, 2011
September 1, 2011
2.9 years
July 20, 2009
September 13, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Willingness to pursue preemptive living donor transplant
pre and post-class
Secondary Outcomes (1)
Preemptive living donor transplant rates
1-2 years
Study Arms (3)
Standard transplant education
NO INTERVENTIONMissouri Kidney Program's standard Patient Education Program (PEP) transplant module.
Transplant education with video
EXPERIMENTALExplore Transplant transplant module featuring video
Transplant education with speakers
EXPERIMENTALExplore Transplant transplant module featuring live guest speakers.
Interventions
1 hour standard transplant module is replaced with the Explore Transplant presentation and 20 minute video featuring transplant patients and donors
1 hour standard transplant module is replaced with the Explore Transplant presentation and 3 live speakers: 1 deceased donor recipient, 1 living donor recipient and 1 living donor
Eligibility Criteria
You may qualify if:
- Chronic kidney disease
- Attend all 6 education modules
- + years of age
- Have given consent by signing informed consent
- Speak and understand English
- Can read and understand questionnaires
You may not qualify if:
- Patients who do not speak and understand English (material is presented orally)
- Patients who cannot read and understand the questionnaires
- Patients who are 17 years of age or younger
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Missouri Kidney Program
Overland Park, Kansas, 66212, United States
Missouri Kidney Program
Springfield, Missouri, 65807, United States
Washington University
St Louis, Missouri, 63110, United States
Missouri Kidney Program
St Louis, Missouri, 63122, United States
Missouri Kidney Program
Warrensburg, Missouri, 64093, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy D Waterman, PhD
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine
Study Record Dates
First Submitted
July 20, 2009
First Posted
January 13, 2010
Study Start
September 1, 2008
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
September 15, 2011
Record last verified: 2011-09